Compounds > 1,4-dihydroxyanthraquinone
Page last updated: 2024-08-17

1,4-dihydroxyanthraquinone and emodin

1,4-dihydroxyanthraquinone has been researched along with emodin in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (50.00)29.6817
2010's2 (25.00)24.3611
2020's2 (25.00)2.80

Authors

AuthorsStudies
Strassburg, CP; Tukey, RH1
Matsuda, H; Morikawa, T; Shimoda, H; Yoshikawa, M1
Coenye, T; Honraet, K; Nadal Jimenez, P; Nelis, HJ; Rigole, P1
Inui, K; Kanamitsu, K; Katayama, W; Kitakami, R; Mizuguchi, M; Nakagawa, S; Nakagawa, Y; Okada, T; Sawai, Y; Toyooka, N; Yokoyama, T1
Lefin, R; Petzer, A; Petzer, JP1
Chaplow, JS; Harman, M; Hopkin, S; Potter, E; Scott, WA; Sims, I; Sorokin, N; Whitaker, J1
Badria, FA; Ibrahim, AS1
Belej, D; Horvath, D; Huntosova, V; Joniova, J; Jurasekova, Z; Kozar, T; Miskovsky, P; Stanicova, J; Verebova, V1

Reviews

1 review(s) available for 1,4-dihydroxyanthraquinone and emodin

ArticleYear
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
    Annual review of pharmacology and toxicology, 2000, Volume: 40

    Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic

2000

Other Studies

7 other study(ies) available for 1,4-dihydroxyanthraquinone and emodin

ArticleYear
Phytoestrogens from the roots of Polygonum cuspidatum (Polygonaceae): structure-requirement of hydroxyanthraquinones for estrogenic activity.
    Bioorganic & medicinal chemistry letters, 2001, Jul-23, Volume: 11, Issue:14

    Topics: Anthraquinones; Cell Division; Cells, Cultured; Emodin; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens, Non-Steroidal; Genistein; Humans; Isoflavones; Phytoestrogens; Plant Preparations; Polygonaceae; Protein Binding; Receptors, Estrogen; Structure-Activity Relationship

2001
In vitro inhibition of Streptococcus mutans biofilm formation on hydroxyapatite by subinhibitory concentrations of anthraquinones.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:4

    Topics: Anthraquinones; Anti-Bacterial Agents; Biofilms; Durapatite; Microbial Sensitivity Tests; Streptococcus mutans

2007
Inhibitory activities of anthraquinone and xanthone derivatives against transthyretin amyloidogenesis.
    Bioorganic & medicinal chemistry, 2021, 08-15, Volume: 44

    Topics: Amyloid Neuropathies, Familial; Anthraquinones; Crystallography, X-Ray; Dose-Response Relationship, Drug; Humans; Models, Molecular; Molecular Structure; Structure-Activity Relationship; Xanthones

2021
Phenothiazine, anthraquinone and related tricyclic derivatives as inhibitors of monoamine oxidase.
    Bioorganic & medicinal chemistry, 2022, 01-15, Volume: 54

    Topics: Anthraquinones; Dose-Response Relationship, Drug; Humans; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Phenothiazines; Structure-Activity Relationship

2022
The comparative toxicity to soil invertebrates of natural chemicals and their synthetic analogues.
    Chemosphere, 2009, Volume: 76, Issue:3

    Topics: Animals; Anthraquinones; Ecotoxicology; Emodin; Naphthoquinones; Oligochaeta; Organic Chemicals; Reproduction; Risk Assessment; Soil

2009
Evaluation of natural anthracene-derived compounds as antimitotic agents.
    Drug discoveries & therapeutics, 2013, Volume: 7, Issue:2

    Topics: Anthracenes; Anthraquinones; Antimitotic Agents; Antineoplastic Agents; Dose-Response Relationship, Drug; Emodin; Mitosis; Onions; Plant Roots; Time Factors

2013
Deeper insights into the drug defense of glioma cells against hydrophobic molecules.
    International journal of pharmaceutics, 2016, Apr-30, Volume: 503, Issue:1-2

    Topics: Anthracenes; Anthraquinones; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Cell Nucleus; Cholesterol, LDL; DNA; Emodin; Glioma; Humans; Hydrophobic and Hydrophilic Interactions; Light; Molecular Docking Simulation; Perylene; Serum Albumin

2016